Key result
Frailty was independently associated with higher long-term all-cause mortality compared to non-frail patients.
Why the study?
Does frailty predict long-term all-cause mortality in elderly patients hospitalized for NSTEMI?
Observational (n=307)
Yes
Does frailty predict long-term all-cause mortality in elderly patients hospitalized for NSTEMI?
Frailty is a strong, independent predictor of long-term all-cause mortality in elderly patients hospitalized for NSTEMI, highlighting its utility alongside comorbidity indices for risk stratification.
Answers are grounded in this paper and cite their sources.
May aid risk stratification; leaves open whether frailty interventions improve survival in cardiac cohorts.
BACKGROUND: There is a growing body of evidence on the relevance of using frailty measures also in a cardiovascular context. The estimated time to death is crucial in clinical decision-making in cardiology. However, data on the importance of frailty in long-term mortality are very scarce. The aim of the study was to assess the prognostic value of frailty on mortality at long-term follow-up of more than 5 years in patients 75 years or older hospitalised for non-ST-segment elevation myocardial infarction. We hypothesised that frailty is independently associated with long-term mortality. DESIGN: This was a prospective, observational study conducted at three centres. METHODS AND RESULTS: Frailty was assessed according to the Canadian Study of Health and Aging clinical frailty scale (CFS). Of 307 patients, 149 (48.5%) were considered frail according to the study instrument (degree 5-7 on the scale). The long-term all-cause mortality of more than 5 years (median 6.7 years) was significantly higher among frail patients (128, 85.9%) than non-frail patients (85, 53.8%), ( P < 0.001). In Cox regression analysis, frailty was independently associated with mortality from the index hospital admission to the end of follow-up (hazard ratio 2.06, 95% confidence interval 1.51-2.81; P < 0.001) together with age ( P < 0.001), ejection fraction ( P = 0.012) and Charlson comorbidity index ( P = 0.018). CONCLUSIONS: In elderly non-ST-segment elevation myocardial infarction patients, frailty was independently associated with all-cause mortality at long-term follow-up of more than 6 years. The combined use of frailty and comorbidity may be the ultimate risk prediction concept in the context of cardiovascular patients with complex needs.
No takes yet. Share an insight, caveat, or question.
Ekerstad et al. (2018) conducted an observational in non-ST-segment elevation myocardial infarction (n=307). Frailty vs. Non-frail was evaluated on all-cause mortality (HR 2.06, 95% CI 1.51-2.81, p=< 0.001). Frailty was independently associated with higher long-term all-cause mortality compared to non-frail patients.
Synapse has enriched 10 related papers. Consider them for comparative context: